Docencia
Early antirretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high income countries : an international collaborative cohort study (28/04/2023)
Dra. Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens (14/04/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Mpox in people with advanced HIV infection: a global case series (31/03/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial (17/03/2023)
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments (03/03/2023)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.
Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort (17/02/2023)
Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort (20/01/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Curso Inmunología para entender todo sobre virus
Sesiones: Ver
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study (09/01/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Stable Latent HIV Infection and Low level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat (09/12/2022)
Dra. Verónica Briz
Centro Nacional de Microbiología.
Instituto de Salud Carlos III.


